Dr. Fischkoff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9 Canoe Brook Rd
Short Hills, NJ 07078Phone+1 973-376-0437
Education & Training
NYU Grossman School of MedicineResidency, Internal Medicine, 1976 - 1979
Perelman School of Medicine at the University of PennsylvaniaClass of 1976
Certifications & Licensure
NY State Medical License 1977 - Present
PA State Medical License 1985 - 2024
MD State Medical License 1981 - 1986- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study of Human Placenta-derived Cells (PDA001) to Evaluate the Safety and Effectiveness for Patients With Active Rheumatoid Arthritis Start of enrollment: 2010 Dec 01
- A Randomized, Double-Blind, Placebo-Controlled Dose-Escalation Study to Determine the Safety and Efficacy of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatment of Crohn's Disease Start of enrollment: 2013 Mar 01
Publications & Presentations
PubMed
- 261 citationsEfficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab')2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels.Edward A. Panacek, John C. Marshall, Timothy E Albertson, David H. Johnson, Steven B. Johnson
Critical Care Medicine. 2004-11-01 - 937 citationsRadiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti–tumor necrosis factor monoclonal antibody) in patients with active rheumatoi...Edward C. Keystone, Arthur Kavanaugh, John T. Sharp, Hyman Tannenbaum, Ye Hua
Arthritis and Rheumatism. 2004-05-01 - 391 citationsAdalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthriti...Daniel E. Furst, Michael Schiff, Roy Fleischmann, Vibeke Strand, C. Birbara
The Journal of Rheumatology. 2003-12-01
Press Mentions
After Decades of Research, Potential for TILs in Melanoma Is Higher Than EverFebruary 20th, 2016
Up and down the Ladder: The Latest Comings and GoingsFebruary 5th, 2016
Lion Biotechnologies Names Steven A. Fischkoff Chief Medical OfficerFebruary 4th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
